✦ LIBER ✦

LOW DOSE SURAMIN AS A CHEMOSENSITIZER OF BLADDER CANCER TO MITOMYCIN C

✍ Scribed by XIN, Y; LYNESS, G; CHEN, D; SONG, S; WIENTJES, M; AU, J

Book ID: 122527155
Publisher: Lippincott Williams and Wilkins
Year: 2005
Tongue: English
Weight: 688 KB
Volume: 174
Category: Article
ISSN: 0022-5347
DOI: 10.1097/01.ju.0000161594.86931.ea

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I Evaluation of Low-Dose Suramin a

Phase I Evaluation of Low-Dose Suramin as Chemosensitizer of Doxorubicin in Dogs with Naturally Occurring Cancers

✍ Carrie E. Kosarek; Xiao Hu; C. Guillermo Couto; William C. Kisseberth; Eric M. G 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB

The effect of intravesical single-dose M

The effect of intravesical single-dose Mitomycin C in recurrent superficial bladder cancer

✍ Benjamin R. Grey; Joanne Butler; Richard A. Darling; Senthil K. Govindaraju; Pat 📂 Article 📅 2009 🏛 SAGE Publications 🌐 English ⚖ 132 KB

Characterization of a human bladder canc

Characterization of a human bladder cancer cell line selected for resistance to mitomycin C

✍ Bing H. Xu; Vicram Gupta; Shivendra V. Singh 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 791 KB

This study describes characteristics of a human bladder cancer cell line J82/MMC that is 6-fold more resistant to mitomycin C (MMC) than the parental cells. The J82/MMC subline was isolated by repeated continuous exposures of the J82/WT cells to increasing concentrations of MMC. The J82/MMC cell lin

S147 A RANDOMIZED STUDY OF SINGLE DOSE I

S147 A RANDOMIZED STUDY OF SINGLE DOSE INTRAVESICAL MITOMYCIN-C IN THE TREATMENT OF SUPERFICIAL BLADDER CANCER

✍ N. Ferakis; T. Granitsas; C. Bouropoulos; I. Arvanitis; N. Charalampogiannis; N. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 591 KB

Low-dose abdominal radiation as a doceta

Low-dose abdominal radiation as a docetaxel chemosensitizer for recurrent epithelial ovarian cancer: A phase I study of the Gynecologic Oncology Group

✍ Charles A. Kunos; Michael W. Sill; Thomas E. Buekers; Joan L. Walker; Jeanne M. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 165 KB

Mechanism of cross-resistance to cisplat

Mechanism of cross-resistance to cisplatin in a mitomycin C-resistant human bladder cancer cell line

✍ Shivendra V. Singh; Bing H. Xu; Jitesh P. Jani; Erling O. Emerson; Mary G. Backe 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 730 KB

This study was undertaken to elucidate the mechanism@) of cross-resistance to cisplatin (CDDP) in a mitomycin C (MMC)resistant human bladder cancer cell line, J82/MMC. The J82/ MMC cell line displayed 2-to 3-fold cross-resistance to CDDP and carboplatin when compared to the parental )82/WT cells. Dr